09.03.19
Don Deihs is retiring from Fitz Chem LLC on Sept. 30, the company announced.
Deihs has successfully led the organization for the last 15 years and transformed relationships with suppliers to drive a focused selling effort that consistently delivered growth rates exceeding the specialty chemical distribution market while building the reputation of Fitz Chem as a “Customer-Centered Distributor.”
His financial acumen and market awareness culminated in the successful sale of Fitz Chem to Nagase Group in 2017.
“I congratulate Don on his retirement," said Ryuichi Uchida, CEO of Nagase Americas. "He has been an important business partner to Nagase and a good friend. Moreover, I am also pleased that Don will continue as an advisor to both the Nagase Holdings of America Advisory Board and Fitz Chem on strategic matters, and I look forward to his contribution on the recently named Prinova Board of Directors, assisting us with our latest North American acquisition.
“I am also pleased to announce that as part of our planned succession, Mark Miller, currently VP - CARE, will ascend to the presidency on Oct. 1," Uchida continued. "Mark has more than 32 years of experience in the process industries of steel and chemicals and has successfully led businesses on the producer and distribution side. I’m confident in his ability to lead Fitz Chem’s overall growth in the Performance Chemicals and Life & HealthCare Segments as we seek to expand our product line representation while adding services to our business.”
Mark Dailey will join as director, CARE, succeeding Miller.
“I’m very proud to have Mark Dailey join and lead our CARE Team as we continue to evolve our business,” Miller said. “His technical knowledge and past leadership will certainly build our presence in the Personal Care, HI&I and OTC Pharma segments.”
Deihs has successfully led the organization for the last 15 years and transformed relationships with suppliers to drive a focused selling effort that consistently delivered growth rates exceeding the specialty chemical distribution market while building the reputation of Fitz Chem as a “Customer-Centered Distributor.”
His financial acumen and market awareness culminated in the successful sale of Fitz Chem to Nagase Group in 2017.
“I congratulate Don on his retirement," said Ryuichi Uchida, CEO of Nagase Americas. "He has been an important business partner to Nagase and a good friend. Moreover, I am also pleased that Don will continue as an advisor to both the Nagase Holdings of America Advisory Board and Fitz Chem on strategic matters, and I look forward to his contribution on the recently named Prinova Board of Directors, assisting us with our latest North American acquisition.
“I am also pleased to announce that as part of our planned succession, Mark Miller, currently VP - CARE, will ascend to the presidency on Oct. 1," Uchida continued. "Mark has more than 32 years of experience in the process industries of steel and chemicals and has successfully led businesses on the producer and distribution side. I’m confident in his ability to lead Fitz Chem’s overall growth in the Performance Chemicals and Life & HealthCare Segments as we seek to expand our product line representation while adding services to our business.”
Mark Dailey will join as director, CARE, succeeding Miller.
“I’m very proud to have Mark Dailey join and lead our CARE Team as we continue to evolve our business,” Miller said. “His technical knowledge and past leadership will certainly build our presence in the Personal Care, HI&I and OTC Pharma segments.”
